Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing
Vyome Holdings, Inc., (“Vyome”) (
NASDAQ: HIND), a next-generation inflammation-focused company leveraging the US–India innovation corridor, today announced its financial results and a series of corporate and clinical milestones following its successful listing on Nasdaq.
Vyome Holdings Announces Results of Annual Shareholder Meeting
Vyome Holdings, Inc. (“Vyome”) (Nasdaq: HIND) announced it held its annual shareholder meeting on October 28, 2025.
